sec filing
CA
NASDAQ · CAMP
CAMP4 Therapeutics Corporation
Healthcare · Biotechnology
$4.41
Down-$0.08 (-1.78%)
Updated Sep 7, 2026, 3:32 PM
SID Score
4.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 125.74M
- P/E ratio
- -2.24
- Dividend yield
- 0.00%
- 52-week range
- $2.90 – $7.75
- Volume
- 131.12K
- Avg. volume
- 166.84K
Price performance
CAMP price history
1M range · 20 trading sessions · Daily adjusted prices
CAMP closed at $4.41 after 20 trading sessions, up 4.50% for the selected period.
- Last close
- $4.41
- Period change
- +4.50%
- Period low
- $3.79
- Period high
- $5.44
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 4, 2026 | $4.45 | $4.64 | $4.331 | $4.41 | 131.12K |
| Sep 3, 2026 | $3.87 | $4.53 | $3.76 | $4.49 | 1.28M |
| Sep 2, 2026 | $3.85 | $4.0695 | $3.78 | $3.80 | 215.2K |
| Sep 1, 2026 | $3.85 | $3.95 | $3.70 | $3.79 | 229.39K |
| Aug 31, 2026 | $4.18 | $4.18 | $3.87 | $3.96 | 190.29K |
| Aug 28, 2026 | $4.18 | $4.30 | $4.03 | $4.15 | 142.06K |
| Aug 27, 2026 | $4.23 | $4.41 | $4.01 | $4.14 | 749.4K |
| Aug 26, 2026 | $4.45 | $4.5283 | $4.05 | $4.20 | 364.5K |
| Aug 25, 2026 | $4.40 | $4.60 | $4.33 | $4.45 | 184.48K |
| Aug 24, 2026 | $4.46 | $4.5173 | $4.26 | $4.32 | 109.48K |
| Aug 21, 2026 | $4.50 | $4.5408 | $4.42 | $4.48 | 126.86K |
| Aug 20, 2026 | $4.57 | $4.9499 | $4.37 | $4.46 | 395.65K |
| Aug 19, 2026 | $4.97 | $5.035 | $4.58 | $4.65 | 228.5K |
| Aug 18, 2026 | $5.00 | $5.1783 | $4.84 | $4.90 | 128.5K |
| Aug 17, 2026 | $5.76 | $6.00 | $4.78 | $5.00 | 563.09K |
| Aug 14, 2026 | $4.50 | $5.48 | $4.21 | $5.44 | 426.63K |
| Aug 13, 2026 | $4.48 | $4.575 | $4.42 | $4.50 | 53.76K |
| Aug 12, 2026 | $4.20 | $4.63 | $4.12 | $4.53 | 493.14K |
| Aug 11, 2026 | $4.23 | $4.33 | $4.135 | $4.17 | 62.36K |
| Aug 10, 2026 | $4.25 | $4.29 | $4.09 | $4.22 | 85.33K |
Latest CAMP news
The latest Smart Investors Daily articles mentioning CAMP.
Stock researchResearch & News · SEC Filings
Loading stock research…